Other
Liraglutide
0
Pipeline Programs↗
2
Active Trials↗
7
Companies Involved↗
Liraglutide is an early-stage landscape with 0 programs across 7 companies. The most active players are Novo Nordisk, Pfizer, Sanofi.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
64
clinical trials
Completed54 · 84%
Unknown status4 · 6%
Recruiting2 · 3%
Withdrawn2 · 3%
Terminated2 · 3%
Clinical Trials
Trial Activity
64 trials
Page 1 of 5
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)